Postponement of results

Dechra Pharmaceuticals PLC
26 June 2023
 

FOR IMMEDIATE RELEASE

26 June 2023

Dechra Pharmaceuticals PLC

("Dechra" or the "Company")

Postponement of the Announcement of the Results for the Financial Year ended 30 June 2023

Dechra announces today that it will not release its results for the financial year ended 30 June 2023 (the "Results") on 4 September 2023 as previously indicated. No revised date for announcing the Results has yet been set but, assuming that Dechra's shares remain listed on the Official List at that time, the Results will be announced by no later than 30 October 2023 in line with Dechra's obligations under the Listing Rules

Enquiries:

TooleyStreet Communications Ltd (PR Adviser to Dechra)

+44 (0) 77 8570 3523

Fiona Tooley, Director


 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Dechra Pharmaceuticals (DPH)
UK 100
FTSE quotes by TradingView

Latest directors dealings

All directors dealings today